1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 11-17 of 17 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trialRichmond, P.; Marshall, H.; Nissen, M.; Jiang, Q.; Jansen, K.; Garces-Sanchez, M.; Martinon-Torres, F.; Beeslaar, J.; Szenborn, L.; Wysocki, J.; Eiden, J.; Harris, S.; Jones, T.; Perez, J.
2012A bivalent Neisserie meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trialRichmond, P.; Nissen, M.; Marshall, H.; Lambert, S.; Roberton, D.; Gruber, W.; Jones, T.; Arora, A.
2006Case for varicella surveillance in AustraliaPeadon, E.; Burgner, D.; Nissen, M.; Buttery, J.; Zurynski, Y.; Elliott, E.; Gold, M.; Marshall, H.; Booy, R.
2011Congenital and neonatal varicella: impact of the national varicella vaccination programme in AustraliaKhandaker, G.; Marshall, H.; Peadon, E.; Zurynski, Y.; Burgner, D.; Buttery, J.; Gold, M.; Nissen, M.; Elliott, E.; Burgess, M.; Booy, R.
2015Predictors of disease severity in children hospitalized for pertussis during an epidemicMarshall, H.; Clarke, M.; Rasiah, K.; Richmond, P.; Buttery, J.; Reynolds, G.; Andrews, R.; Nissen, M.; Wood, N.; Mcintyre, P.
2012Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trialsBryant, K.; McVernon, J.; Marchant, C.; Nolan, T.; Marshall, G.; Richmond, P.; Marshall, H.; Nissen, M.; Lambert, S.; Aris, E.; Mesaros, N.; Miller, J.
2012Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: A phase 1 randomized-controlled clinical trialMarshall, H.; Richmond, P.; Nissen, M.; Jiang, Q.; Anderson, A.; Jansen, K.; Reynolds, G.; Ziegler, J.; Harris, S.; Jones, T.; Perez, J.

Discover